PBRM1 and nonpapillary renal cell carcinoma: (7) performed whole-exome sequencing of metastatic ccRCC and proposed that PBRM1 loss in ccRCC may play an important role in the formation of differentiated immune expression landscape and subgroup-specific tumor immune infiltrating microenvironment influencing responsiveness to immune checkpoint therapy.